Sanjiv Sharma is joining Infant Bacterial Therapeutics as the new Chief Commercial Officer. Sanjiv brings to Infant Bacterial Therapeutics his long experience of launching companies and optimizing the market performance of new and existing pharmaceutical products through shrewd commercial strategy and disciplined implementation.
See Who we are here